766 related articles for article (PubMed ID: 31492150)
1. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
Gong Y; Luo G; Zhang S; Chen Y; Hu Y
Cell Signal; 2024 May; 117():111068. PubMed ID: 38286198
[TBL] [Abstract][Full Text] [Related]
4. METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1.
Yang R; Yang C; Su D; Song Y; Min J; Qian Z; Shen X; Li J; Su H
Cancer Gene Ther; 2024 Apr; 31(4):562-573. PubMed ID: 38267624
[TBL] [Abstract][Full Text] [Related]
5. METTL3 Promotes Osteosarcoma Metastasis via an m6A-dependent Epigenetic Activity of CBX4.
Huo XS; Lu D; Chen DG; Ye M; Wang XW; Shang FS
Front Biosci (Landmark Ed); 2024 Mar; 29(3):120. PubMed ID: 38538251
[TBL] [Abstract][Full Text] [Related]
6. METTL3-mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway.
Jia J; Yu L
Environ Toxicol; 2024 May; 39(5):2830-2841. PubMed ID: 38293837
[TBL] [Abstract][Full Text] [Related]
7. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis.
Ouyang P; Li K; Xu W; Chen C; Shi Y; Tian Y; Gong J; Bao Z
J Exp Clin Cancer Res; 2024 Apr; 43(1):111. PubMed ID: 38605400
[TBL] [Abstract][Full Text] [Related]
8. Methyltransferase METTL3-mediated maturation of miR-4654 facilitates high glucose-induced apoptosis and oxidative stress in lens epithelial cells via decreasing SOD2.
Guo M; Su F; Chen Y; Su B
Chem Biol Drug Des; 2024 Feb; 103(2):e14491. PubMed ID: 38404215
[TBL] [Abstract][Full Text] [Related]
9. METTL3 suppresses invasion of lung cancer via SH3BP5 m6A modification.
Zhang B; Qian R; Li X
Arch Biochem Biophys; 2024 Feb; 752():109876. PubMed ID: 38141906
[TBL] [Abstract][Full Text] [Related]
10. The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis.
Chen K; Zhang J; Meng L; Kong L; Lu M; Wang Z; Wang W
J Exp Clin Cancer Res; 2024 Feb; 43(1):44. PubMed ID: 38326863
[TBL] [Abstract][Full Text] [Related]
11. m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis.
Tian Q; Mu Q; Liu S; Huang K; Tang Y; Zhang P; Zhao J; Shu C
Carcinogenesis; 2023 Dec; 44(12):859-870. PubMed ID: 37738681
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a.
Zhong C; Tao B; Yang F; Xia K; Yang X; Chen L; Peng T; Xia X; Li X; Peng L
Clin Transl Med; 2021 Sep; 11(9):e424. PubMed ID: 34586733
[TBL] [Abstract][Full Text] [Related]
13. METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability.
Chen Z; Zhou J; Wu Y; Chen F; Li J; Tao L; Tian Y; Wang H; Li J; Li Z; He W; Zhang K; Wang H
Oncogene; 2024 Mar; 43(13):976-991. PubMed ID: 38361047
[TBL] [Abstract][Full Text] [Related]
14. CBX2 Deletion Suppresses Growth and Metastasis of Colorectal Cancer by Mettl3-p38/ERK MAPK Signalling Pathway.
Sun R; Tu X; Chan S; Wang X; Ji Y; Wang Z; Yu Z; Zuo X; Zhang Q; Chen J; Han Q; Wang M; Zhao H; Zhang H; Chen W
J Cancer; 2024; 15(8):2123-2136. PubMed ID: 38495501
[TBL] [Abstract][Full Text] [Related]
15. Specific deletion of Mettl3 in IECs triggers the development of spontaneous colitis and dysbiosis of T lymphocytes in mice.
Fang M; Yao J; Zhang H; Sun J; Yin Y; Shi H; Jiang G; Shi X
Clin Exp Immunol; 2024 Mar; ():. PubMed ID: 38507548
[TBL] [Abstract][Full Text] [Related]
16. Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3.
Cesaro B; Iaiza A; Piscopo F; Tarullo M; Cesari E; Rotili D; Mai A; Diana A; Londero M; Del Giacco L; Masetti R; Di Leone A; Naro C; Masciarelli S; Fontemaggi G; Sette C; Fazi F; Fatica A
Cancer Commun (Lond); 2024 Feb; 44(2):282-286. PubMed ID: 38102821
[No Abstract] [Full Text] [Related]
17. METTL3-Mediated m6A Modification Links Liver Homeostasis and Pathology.
Ma W; Wu T
Am J Pathol; 2022 Jan; 192(1):18-20. PubMed ID: 34774849
[No Abstract] [Full Text] [Related]
18. Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages.
Sturgess K; Yankova E; Vijayabaskar MS; Isobe T; Rak J; Kucinski I; Barile M; Webster NA; Eleftheriou M; Hannah R; Gozdecka M; Vassiliou G; Rausch O; Wilson NK; Göttgens B; Tzelepis K
Leukemia; 2023 Oct; 37(10):2133-2137. PubMed ID: 37464070
[No Abstract] [Full Text] [Related]
19. METTL3 restrains autoimmunity in β-cells.
Krishnamurthy B; Thomas HE
Nat Cell Biol; 2024 Mar; 26(3):321-322. PubMed ID: 38409326
[No Abstract] [Full Text] [Related]
20. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
